Dr. Sean McGinley

Dr. Sean McGinley
Sean T. McGinley, MD, received his undergraduate degree from The University of Pennsylvania, graduating magna cum laude and serving as team captain and Dean’s List member of the varsity cross country and track teams. He then earned his medical degree from The Albert Einstein College of Medicine in New York City, where he was selected to join the Alpha Omega Alpha National Medical Honor Society. Dr. McGinley completed residency in urologic surgery at University at Buffalo in New York, where he served as the academic and administrative chief resident and was awarded the 2019 Louis A. and Ruth Siegel Resident Teaching Award. During this time, he was also published in numerous journals and presented his research locally, regionally and internationally. Dr. McGinley belongs to several medical societies, including The American Urological Association, American Medical Association, Pennsylvania Medical Society, Northeastern Section of the American Urological Association, Endourological Society, and the Alpha Omega Alpha Medical Honor Society. Dr. McGinley cares for patients facing a variety of general urologic issues, although he has a particular interest in kidney stone disease and BPH. He offers a wide range of minimally invasive approaches. He endeavors to provide compassionate and state of the art care, while prioritizing education to empower his patients in their care.

Languages Spoken:


Medical School:

Albert Einstein College of Medicine (Bronx, NY)


University at Buffalo


University of Pennsylvania

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only